Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8845085 | 1.00 | MEN1 (0.38) | MEN1KMT2ACYP2D6TSHRLMNA | |
| SCHEMBL12470582 | 1.00 | MEN1 (0.38) | MEN1KMT2ACYP2D6TSHRLMNA | |
| SCHEMBL8844911 | 1.00 | MEN1 (0.38) | MEN1KMT2ACYP2D6TSHRLMNA | |
| SCHEMBL1059947 | 1.00 | — | — | |
| SCHEMBL18534321 | 1.00 | MEN1 (0.38) | MEN1KMT2ACYP2D6TSHRLMNA | |
| SCHEMBL19249362 | 1.00 | MEN1 (0.38) | MEN1KMT2ACYP2D6TSHRLMNA | |
| Hydrochloric Acid SCHEMBL27758922 | 0.97 | — | — | |
| SCHEMBL69143 | 0.97 | — | — | |
| Methane SCHEMBL705841 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL16777054 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1997027746-A1 | WHITEFLY INSECTICIDE | TARGOSZ EUGENE F (US) | 1997-08-07 | — | — | WO | claimed |
| US-12016865-B2 | Methods and pharmaceutical compositions for treating candida auris in blood | CORMEDIX INC. (US) | 2024-06-25 | — | — | US | disclosed |
| EP-3313857-B1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | WU NIAN (US) | 2021-01-06 | — | — | EP | disclosed |
| US-10835608-B2 | Polymer-carbohydrate conjugates for drug delivery technology | LIPOSEUTICALS INC | 2020-11-17 | — | — | US | disclosed |
| EP-3727393-A2 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CANDIDA AURIS IN BLOOD | CorMedix Inc. (US) | 2020-10-28 | — | — | EP | disclosed |
| EP-3077006-B1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | WU NIAN (US) | 2020-08-19 | — | — | EP | disclosed |
| US-20190192529-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CANDIDA AURIS IN BLOOD | CORMEDIX INC. | 2019-06-27 | — | — | US | disclosed |
| US-10064954-B2 | Polymer-cyclodextrin-lipid conjugates | LIPOSEUTICALS INC | 2018-09-04 | — | — | US | disclosed |
| EP-2673000-B1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2018-05-16 | — | — | EP | disclosed |
| EP-3313857-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | Wu, Nian (US) | 2018-05-02 | — | — | EP | disclosed |
| WO-2013003306-A1 | PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION | WU NIAN (US) | 2013-01-03 | — | — | WO | disclosed |
| US-20130004592-A1 | PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION | LIPOSEUTICALS, INC. | 2013-01-03 | — | — | US | disclosed |
| US-8304565-B2 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2012-11-06 | — | — | US | disclosed |
| US-20120202890-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-09 | — | — | US | disclosed |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPOSEUTICALS, INC. | 2012-08-09 | — | — | US | disclosed |
| WO-2011139343-A2 | AMINO ACID LINKED PEG-LIPID CONJUGATES | WU NIAN (US) | 2011-11-10 | — | — | WO | disclosed |
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2010-03-25 | — | — | US | disclosed |
| US-5658954-A | NONTOXIC TO HUMAN, ANIMALS; MIXTURE OF COTTONSEED OIL AMIDE, COCONUT OIL AMIDE, TALL OIL AMIDE, NONIONIC SURFACTANT, CHELATE COMPOUND AND FLOW CONTROL AGENT | TARGOSZ EUGENE F (US) | 1997-08-19 | — | — | US | disclosed |
| WO-1997027746-A1 | WHITEFLY INSECTICIDE | TARGOSZ EUGENE F (US) | 1997-08-07 | — | — | WO | disclosed |
| US-5496857-A | ALKANOL AMIDES OF COTTONSEED, COCONUT AND TALL OIL, NONIONIC SURFACTANTS | TARGOSZ EUGENE F (US) | 1996-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | DAGLA, DAGLB, DGKG | MEN1 2105/4885KMT2A 4305/4885CYP2D6 1508/4885 |
| US-10835608-B2 | Polymer-carbohydrate conjugates for drug delivery technology | LIPC, FABP4, CETP | MEN1 2733/4885KMT2A 1977/4885CYP2D6 86/4885 |
| US-20130004592-A1 | PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL ADMINISTRATION | LIPC, CETP, UGCG | MEN1 2846/4885KMT2A 3533/4885CYP2D6 120/4885 |
| US-10064954-B2 | Polymer-cyclodextrin-lipid conjugates | CETP, FABP4, PLIN3 | MEN1 3960/4885KMT2A 4200/4885CYP2D6 79/4885 |
| US-20120202890-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPC, FUT6, UGCG | MEN1 1849/4885KMT2A 1692/4885CYP2D6 408/4885 |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPC, FUT6, UGCG | MEN1 1849/4885KMT2A 1692/4885CYP2D6 408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.